IEQ Capital’s Blueprint Medicines BPMC Stock Holding History

IEQ Capital’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,450	Closed	-$1.6M	–	1869
2025 Q2	$1.6M	Sell	12,450 -609	-5%	-$63.3K	0.01%	709
2025 Q1	$1.16M	Buy	13,059 +2,896	+28%	+$283K	0.01%	716
2024 Q4	$886K	Buy	+10,163	New	+$931K	0.01%	693

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

IEQ Capital's BPMC Position: Q3 2025 in Review

IEQ Capital sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 12,450 shares — an estimated $1.6M sold.

IEQ Capital first reported a position in BPMC in Q4 2024 and held it in 3 quarters. The position peaked at $1.6M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

IEQ Capital reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
IEQ Capital sold 12,450 Blueprint Medicines shares in Q3 2025, an estimated $1.6M.
IEQ Capital first reported a position in Blueprint Medicines in Q4 2024 and held it in 3 quarters.
IEQ Capital's Blueprint Medicines position peaked at $1.6M in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on IEQ Capital's 13F filing for Q3 2025, filed 14 Nov 2025.